DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20181192

Atrial fibrillation: a rare but probable adverse effect of sildenafil

Manish Ruhela, Rajeev Bagarhatta

Abstract


Knowledge of the cardiovascular effects of sildenafil is important for a number of reasons. The main risk factors for the erectile dysfunction (hypercholesterolemia, hypertension, diabetes, smoking) are the same as those for coronary artery disease. The reported cardiovascular side effects of sildenafil in normal healthy population are minor and mainly associated with vasodialation (i.e. headache, flushing and small decrease in systolic and diastolic blood pressure). Authors report the occurrence of atrial fibrillation after the use of sildenafil in a normal healthy individual. To the best of our knowledge, there are only few case reports in the literature showing occurrence of atrial fibrillation with use of sildenafil.


Keywords


Atrial fibrillation, Drug induced, Sildenafil

Full Text:

PDF

References


Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 2006;5:689-702.

Hayashi K, Minezaki KK, Narukawa M, Ookubo M, Mitsuhashi T, Shimada K. Atrial fibrillation and continuous hypotension induced by sildenafil in an intermittent WPW syndrome patient. Jpn Heart J. 1999;40:827-30.

Shah PK. Sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;339:699.

Awan GM, Calderon E, Dawood G, Alpert MA. Acute, symptomatic atrial fibrillation after sildenafil citrate therapy in a patient with hypertrophic obstructive cardiomyopathy. Am J Med Sci. 2000;320:69-71.

Hahn IH, Hoffman RS. Aroused to atrial fibrillation? Am J Emerg Med. 2000;18:642.

Van der Hooft CS, Heeringa J, van Herpen G, et al. Drug-induced atrial fibrillation. J Am Coll Cardiol. 2004;44:2117-24.

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology & Therapeutics. 1981 Aug 1;30(2):239-45.